About Jennifer Ahlstrom

Articles by Jennifer Ahlstrom

Why Some Myeloma Patients Lose the BCMA Target After BCMA-Directed Therapy
Mar 09, 2021
The Need for Myeloma Expertise: Beth Ayen's Story
Mar 07, 2021
What Is Multiple Myeloma and Where Can I Find Help?
Mar 02, 2021
Patrick and Kushla's New Zealand Multiple Myeloma Story
Feb 23, 2021
Clinical Trial: New Phase II Trial Opens for Pfizer's Multiple Myeloma Bispecific Antibody Elrantamab
Feb 18, 2021
Michelle Peterson's Myeloma Journey: A Non-Working Twin Allo Transplant But a Great Outcome
Feb 17, 2021
John Miller's Expanded Vision after His Multiple Myeloma Stem Cell Transplant
Feb 08, 2021
ONJ and Multiple Myeloma
Jan 28, 2021
Blood Type and Multiple Myeloma Outcomes
Jan 13, 2021
Pesticide Use Linked to Myeloma Precursor Conditions
Jan 12, 2021
Underweight or Overweight: Myeloma Patients Have the Best Outcomes with Stable, Healthy Weight
Jan 07, 2021
Reasons to Relax: How Stress Hormones can Trigger Cancer Regrowth
Dec 30, 2020
FDA Approves Selinexor for use After First Line Multiple Myeloma Therapy
Dec 18, 2020
Study Results Show Selinexor (XPOVIO) with Bortezomib and Dex to be a Convenient and Effective Triplet Combination
Nov 13, 2020
CrowdCare Foundation Changes its Name to HealthTree Foundation
Nov 10, 2020
Myeloma Crowd Research Initiative: Diet in MGUS and Smoldering Myeloma to Prevent Progression with Urvi Shah, MD of MSKCC
Nov 09, 2020
Myeloma Crowd Research Initiative: Stem Cell Transplant Use and Impact in Multiple Myeloma
Nov 09, 2020
Myeloma Crowd Research Initiative: Side Effect Solutions
Nov 09, 2020
Silicone Breast Implants and Multiple Myeloma
Oct 22, 2020
Our Next Show: Venetoclax Uses in Multiple Myeloma for t(11;14) Patients and Beyond with Jonathan Kaufman, Emory University Winship Cancer Institute, Friday, Oct 23 @ 2 pm Eastern
Oct 21, 2020
What to Ask Your Doctor at Your First Multiple Myeloma Appointment
Oct 08, 2020
How Pomalidomide Works to Kill Multiple Myeloma
Sep 23, 2020
MRD Negativity is Better than Stringent Complete Response (sCR) to Determine Myeloma Patient Outcomes
Sep 17, 2020
Ninlaro with Dex and Revlimid Extends Survival for Newly Diagnosed, Transplant Ineligible Myeloma Patients
Sep 11, 2020